Skip to content

Hydrocel Vertebral Body Replacement, Model 06-172-00XX1

by Implex Corp.

510(k) K022563

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK022563 Date30 Aug 2002ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MQP
Device Class
Class II
Regulation
21 CFR Part 888.3060
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 23 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Hydrocel Vertebral Body Replacement is a spinal vertebral body replacement device intended for use in the thoracolumbar spine. It consists of a porous tantalum coating deposited on a vitreous carbon skeleton, designed to replace diseased or damaged vertebral bodies and adjacent discs via an anterior approach.

The device is available in various cross-sections and heights with rippled superior and inferior surfaces for stability and included angles to maintain lumbar contour. It is supplied as a sterile, single-use implant and is classified as a Class II device under FDA 510(k) clearance K022563 with product code MQP, subject to special controls.

Other devices from Implex Corp.

See all devices from Implex Corp. →

Questions

AI-generated answers, 23 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What anatomical region is the Hydrocel device intended to treat?

    It is designed for the thoracolumbar spine, replacing diseased or damaged vertebral bodies and adjacent discs in that region. The anterior approach allows direct access to these levels while preserving surrounding structures.

  • How is the implant supplied and what are its sterility requirements?

    The device is supplied as a sterile, single‑use implant. Sterility is maintained until the point of use, and the implant is not intended for re‑sterilization or reuse, ensuring consistent performance and infection control.

  • What materials compose the Hydrocel vertebral body replacement and why?

    It combines a porous tantalum coating with a vitreous carbon skeleton. Tantalum provides a highly porous, osteoconductive surface for bone ingrowth, while vitreous carbon offers structural strength and biocompatibility, together supporting stable spinal reconstruction.

  • What regulatory classification does this device have and what does that imply?

    Classified as a Class II device under FDA 510(k) clearance (K022563) with product code MQP, it is subject to special controls. This means the device must meet specific performance standards and labeling requirements before it can be marketed.